scRNA-seq showed skull-resident B cells dominate brain antigen sampling at this slow border. They upregulate MHC I and tolerogenic markers (PD-L1, Il10ra, Cd1d1), suggesting that the skull functions as an immune-tolerance niche for brain-derived proteins.
